K J Pasi - JoVE Visualize

Showing results (21-30 of 59) with videos related to

Pageof 6

Sort By:

Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016

Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrateP W Collins, E Goldman, P Lilley, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 10, 1997

Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiencyG Evans, K J Pasi, A Mehta, et al.

European Journal of Haematology|April 16, 2003

Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraceptionW C Yoong, S M Tuck, K J Pasi, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016

Cytolytic activity against mycobacterial antigens: differences between haemophiliacs with and without HIV infectionK J Pasi, J A Evans, M Forte, et al.

Thrombosis and Haemostasis|October 6, 1997

Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII productT T Yee, M D Williams, F G Hill, et al.

Thrombosis and Haemostasis|November 19, 1997

von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic useP J Murdock, B J Woodhams, K B Matthews, et al.

Thrombosis Research|August 1, 1990

Qualitative and quantitative abnormalities of von Willebrand antigen in patients with diabetes mellitusK J Pasi, M S Enayat, P M Horrocks, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|August 9, 2014

Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experienceP Batty, Y-H Chen, L Bowles, et al.

British Journal of Haematology|February 26, 2000

Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding historyI C Nitu-Whalley, C A Lee, A Griffioen, et al.

Journal of Medical Virology|January 1, 1990

Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitisS J Skidmore, K J Pasi, S J Mawson, et al.

Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:

Pageof 6

Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016

Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrateP W Collins, E Goldman, P Lilley, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 10, 1997

Recurrent venous thromboembolic disease and factor XI concentrate in a patient with severe factor XI deficiency, chronic myelomonocytic leukaemia, factor V Leiden and heterozygous plasminogen deficiencyG Evans, K J Pasi, A Mehta, et al.

European Journal of Haematology|April 16, 2003

Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraceptionW C Yoong, S M Tuck, K J Pasi, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016

Cytolytic activity against mycobacterial antigens: differences between haemophiliacs with and without HIV infectionK J Pasi, J A Evans, M Forte, et al.

Thrombosis and Haemostasis|October 6, 1997

Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII productT T Yee, M D Williams, F G Hill, et al.

Thrombosis and Haemostasis|November 19, 1997

von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic useP J Murdock, B J Woodhams, K B Matthews, et al.

Thrombosis Research|August 1, 1990

Qualitative and quantitative abnormalities of von Willebrand antigen in patients with diabetes mellitusK J Pasi, M S Enayat, P M Horrocks, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|August 9, 2014

Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experienceP Batty, Y-H Chen, L Bowles, et al.

British Journal of Haematology|February 26, 2000

Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding historyI C Nitu-Whalley, C A Lee, A Griffioen, et al.

Journal of Medical Virology|January 1, 1990

Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitisS J Skidmore, K J Pasi, S J Mawson, et al.

Pageof 6